These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 29145769)

  • 1. Exact statistical calculation of the uncertainty term in the decision limits of the GH-2000 score for growth hormone misuse (doping) detection.
    Böhning D; Liu W; Holt RI; Böhning W; Guha N; Sönksen P; Cowan D; Liang T
    Stat Methods Med Res; 2019 Mar; 28(3):928-936. PubMed ID: 29145769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statistical methodology for age-adjustment of the GH-2000 score detecting growth hormone misuse.
    Böhning D; Böhning W; Guha N; Cowan DA; Sönksen PH; Holt RI
    BMC Med Res Methodol; 2016 Oct; 16(1):147. PubMed ID: 27793179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The development of decision limits for the implementation of the GH-2000 detection methodology using current commercial insulin-like growth factor-I and amino-terminal pro-peptide of type III collagen assays.
    Erotokritou-Mulligan I; Guha N; Stow M; Bassett EE; Bartlett C; Cowan DA; Sönksen PH; Holt RI
    Growth Horm IGF Res; 2012 Apr; 22(2):53-8. PubMed ID: 22305721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The development of decision limits for the GH-2000 detection methodology using additional insulin-like growth factor-I and amino-terminal pro-peptide of type III collagen assays.
    Holt RI; Böhning W; Guha N; Bartlett C; Cowan DA; Giraud S; Bassett EE; Sönksen PH; Böhning D
    Drug Test Anal; 2015 Sep; 7(9):745-55. PubMed ID: 25645199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of normal distribution-based and nonparametric decision limits on the GH-2000 score for detecting growth hormone misuse (doping) in sport.
    Liu W; Bretz F; Böhning D; Holt R; Böhning W; Guha N; Sönksen P; Cowan D
    Biom J; 2021 Jan; 63(1):187-200. PubMed ID: 33164238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined statistical decision limits based on two GH-2000 scores for the detection of growth hormone misuse.
    Liu W; Bretz F; Böhning D; Holt RIG; Han Y; Böhning W; Guha N; Cowan DA
    Stat Methods Med Res; 2022 Aug; 31(8):1439-1448. PubMed ID: 35611962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A correction to the age-adjustment of the GH-2000 score used in the detection of growth hormone misuse.
    Böhning D; Böhning W; Guha N; Cowan DA; Bartlett C; Sönksen PH; Holt RIG
    BMC Res Notes; 2018 Sep; 11(1):650. PubMed ID: 30185229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum insulin-like growth factor-I and pro-collagen type III N-terminal peptide in adolescent elite athletes: implications for the detection of growth hormone abuse in sport.
    Guha N; Erotokritou-Mulligan I; Burford C; Strobridge G; Brigg J; Drake T; Bassett EE; Cowan D; Bartlett C; Sönksen PH; Holt RI
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2969-76. PubMed ID: 20410221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Procollagen type III amino-terminal propeptide and insulin-like growth factor I as biomarkers of growth hormone administration.
    Cowan DA; Moncrieffe DA
    Drug Test Anal; 2022 May; 14(5):808-819. PubMed ID: 34418311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A robust test for growth hormone doping--present status and future prospects.
    Nelson AE; Ho KK
    Asian J Androl; 2008 May; 10(3):416-25. PubMed ID: 18385903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of growth hormone (GH)-dependent markers in the detection of GH abuse in sport: Physiological intra-individual variation of IGF-I, type 3 pro-collagen (P-III-P) and the GH-2000 detection score.
    Erotokritou-Mulligan I; Eryl Bassett E; Cowan DA; Bartlett C; Milward P; Sartorio A; Sönksen PH; Holt RI
    Clin Endocrinol (Oxf); 2010 Apr; 72(4):520-6. PubMed ID: 19650783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinally monitoring of P-III-NP, IGF-I, and GH-2000 score increases the probability of detecting two weeks' administration of low-dose recombinant growth hormone compared to GH-2000 decision limit and GH isoform test and micro RNA markers.
    Lehtihet M; Bhuiyan H; Dalby A; Ericsson M; Ekström L
    Drug Test Anal; 2019 Mar; 11(3):411-421. PubMed ID: 30223291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical markers of insulin-like growth factor-I misuse in athletes: the response of serum IGF-I, procollagen type III amino-terminal propeptide, and the GH-2000 score to the administration of rhIGF-I/rhIGF binding protein-3 complex.
    Guha N; Erotokritou-Mulligan I; Bartlett C; Nevitt SP; Francis M; Bassett EE; Cowan DA; Sönksen PH; Holt RI
    J Clin Endocrinol Metab; 2014 Jun; 99(6):2259-68. PubMed ID: 24606087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detecting growth hormone abuse in athletes.
    Holt RI
    Drug Test Anal; 2009 Sep; 1(9-10):426-33. PubMed ID: 20355225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factor-I (IGF-I) misuse in athletes and potential methods for detection.
    Guha N; Cowan DA; Sönksen PH; Holt RI
    Anal Bioanal Chem; 2013 Dec; 405(30):9669-83. PubMed ID: 23934394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a microplate duplex immunoassay to simplify detection of growth hormone doping: Proof of concept.
    Marchand A; Roy D; Monsheimer SA; Lewis J; Ericsson M
    Drug Test Anal; 2022 Apr; 14(4):724-732. PubMed ID: 34761559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. hGH isoform differential immunoassays applied to blood samples from athletes: decision limits for anti-doping testing.
    Hanley JA; Saarela O; Stephens DA; Thalabard JC
    Growth Horm IGF Res; 2014 Oct; 24(5):205-15. PubMed ID: 24973245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of a freeze-thaw cycle and pre-analytical storage temperature on the stability of insulin-like growth factor-I and pro-collagen type III N-terminal propeptide concentrations: Implications for the detection of growth hormone misuse in athletes.
    Guha N; Erotokritou-Mulligan I; Bartlett C; Cowan DA; Bassett EE; Stow M; Sönksen PH; Holt RI
    Drug Test Anal; 2012 Jun; 4(6):455-9. PubMed ID: 22511534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detecting growth hormone abuse in athletes.
    Holt RI
    Anal Bioanal Chem; 2011 Aug; 401(2):449-62. PubMed ID: 21590497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin, growth hormone and sport.
    Sonksen PH
    J Endocrinol; 2001 Jul; 170(1):13-25. PubMed ID: 11431133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.